14th European Congress of Clinical Microbiology and Infectious ...

Poster Sessions Tuesday, May 4, 2004
P1677 Assessment of documentation of markers of
sepsis and appropriateness of antimicrobial
prescribing in an acute medical admission
unit prior to and following the introduction
of a sepsis stamp
D. Robson, A.M. Cadwgan, K.D. Wares,
R.B.S. Laing, J.G. Douglas, A.R. Mackenzie
(Aberdeen, UK)
P1678 Levofloxacin experience in a general hospital
J. De La Torre, J.L. Prada, A. Del Arco, J. Aguilar,
F. Moreno, N. Montiel, I. Lopez (Marbella, E)
P1680 Characterisation of Staphylococcus xylosus
strains isolated from humans clinical material
D. Kuboskova, I. Sedlacek, P. Svec, P. Petras
(Brno, Prague, CZ)
P1681 Staphylococcus lugdunensis: an overlooked
but easy identifiable, frequent cause of
abscesses in general practice
S. Böcher, J. Prag (Viborg, DK)
P1682 Frequency and clinical spectrum of
Staphylococcus lugdunensis infections –
a French national survey: preliminary results
V. Blanc, R. Sanchez – Collège de Bactériologie
Virologie Hygiène des Hôpitaux
(ColBVH Study Group), France
P1683 Changes in management and outcome of
Staphylococcus aureus bacteraemia
1996–2003
S. Bold, P. Vernazza, S. Henz, G. Eich
(St. Gallen, CH)
P1684 Clinical aspects and risk factors for mortality
of Staphylococcus aureus sepsis in a Swiss
tertiary centre
C. Kaech, L. Elzi, P. Sendi, R. Frei, U. Fluckiger
(Basle, CH)
P1685 Microbiological results from a randomised,
open-label study of ertapenem vs
piperacillin/tazobactam for the treatment
of community-acquired intra-abdominal
infections requiring surgery
A. Dela Pena, W. Asperger, B. Warren, R. Kafka,
R. Raz, M. Shivaprakash, F. Vrijens, H. Giezek,
C. Chan, M. Stek (Manila, PH; Halle, D; Parow, ZA;
Innsbruck, A; Afula, IL; Whitehouse Station, USA;
Brussels, B)
P1686 Ertapenem versus piperacillin/tazobactam for
the treatment of intra-abdominal infections
requiring surgical intervention (OASIS-1):
results of a prospective, randomized,
open-label study
A. Dela Pena, W. Asperger, F. Köckerling, R. Raz,
R. Kafka, B. Warren, M. Shivaprakash, F. Vrijens,
H. Giezek, C. Chan
(Manila, PH; Halle, Hannover, D; Afula, IL;
Innsbruck, A; Parow, ZA; Whitehouse Station, USA;
Brussels, B)
P1687 A prospective randomised trial comparing
cefepime plus metronidazole and imipenemcilastatin
for the treatment of intra-abdominal
infections
J. Garbino, P. Villiger, A. Caviezel, I. Uckay,
P. Morel, R. Matulionyte, A. Ondrusova,
M. Puppo, D. Lew (Geneva, CH)
P1688 Microbiology and empirical treatment
of pyogenic liver abscesses:
analysis of 105 cases
I. Terrancle, F. Mateos, L. Fuentes, R. Arjona,
J.L. Pérez-Arellano, B. Roca, F. Marcos,
I. Tárraga, J.J. Blanch, A. Hdez-Belmonte,
E. Martínez-Alfaro
from the Infectious Diseases Group of the
Spanish Society for Internal Medicine (SEMI)
P1689 Pyogenic liver abscess. A multicentre
experience in management
F. Mateos, I. Terrancle, R. Arjona, L. Fuentes,
M. Hernandez, B. Roca, F. Marcos, I. Tárraga,
J.J. Blanch, E. Martínez-Alfaro
from the Infectious Diseases Group of the
Spanish Society for Internal Medicine (SEMI)
P1690 Two vs four weeks ceftriaxone+metranidazol
treatment in percutaneously drained
pyogenic liver absecess: preliminary report
C. Agalar, S. Soylu, H. Donmez, F. Agalar,
E. Tutuncu, S. Gul, C. Diri, R. Turkyilmaz
(Ankara, TR)
P1691 Micro-organisms isolated from exit site of
peritoneal catheters in patients submitted
to chronic ambulatory peritoneal dialysis
E. Garcia-Peñuela, A. Perez de Ayala,
D. Domingo, D. Monclus, A. Cirugeda,
M. Lopez-Brea (Madrid, E)
P1692 Vertebral osteomyelitis in patients with
HIV-infection
M.E. Jiménez-Mejías, J.D. Colmenero, C. López
Casanova, J.D. Ruiz-Mesa, J. Palomino-Nicás,
J.M. Reguera Iglesias, A. Plata, J. Pachón-Díaz
(Seville, Málaga, E)
www.escmid.org/eccmid2004
page 135